SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-013212
Filing Date
2022-07-27
Accepted
2022-07-27 16:11:40
Documents
14
Period of Report
2022-07-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tern-20220726.htm   iXBRL 8-K 59867
2 EX-99.1 tern-ex99_1.htm EX-99.1 18426
3 GRAPHIC img52906712_0.jpg GRAPHIC 6619
  Complete submission text file 0000950170-22-013212.txt   217436

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tern-20220726_lab.xml EX-101.LAB 14564
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tern-20220726_pre.xml EX-101.PRE 10683
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tern-20220726.xsd EX-101.SCH 2478
8 EXTRACTED XBRL INSTANCE DOCUMENT tern-20220726_htm.xml XML 5117
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 221111139
SIC: 2834 Pharmaceutical Preparations